MICHELE POULOS: Open Payments
NPI 1053484287 · SANDUSKY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,493 in 87 payments from 21 companies in 2025. Trend: 2023 $1,286 · 2024 $1,839 · 2025 $1,493
Food & beverage: $1,493
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $308 |
| ABBVIE INC. | 13 | $233 |
| Otsuka America Pharmaceutical, Inc. | 11 | $170 |
| AstraZeneca Pharmaceuticals LP | 8 | $157 |
| Exact Sciences Corporation | 6 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $62 |
| PFIZER INC. | 3 | $52 |
| Lilly USA, LLC | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $35 |
Products named: REXULTI, Ozempic, UBRELVY, Rybelsus, The Cologuard Plus Collection Kit, BREZTRI, JARDIANCE, Kerendia.
Industry payments across OH — which companies pay providers there.
